Tech Company Financing Transactions

Immunome Funding Round

Immunome, based in Exton, secured $5 million from private investors.

Transaction Overview

Company Name
Announced On
5/31/2017
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 48 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
665 Stockton Dr. 300
Exton, PA 19341
USA
Email Address
Overview
Immunome (Nasdaq: IMNM) is a biopharmaceutical company with a patented native, human antibody platform which enables us to harness the natural curative power of the human immune system.
Profile
Immunome LinkedIn Company Profile
Social Media
Immunome Company Twitter Account
Company News
Immunome News
Facebook
Immunome on Facebook
YouTube
Immunome on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Purnanand Sarma
  Purnanand Sarma LinkedIn Profile  Purnanand Sarma Twitter Account  Purnanand Sarma News  Purnanand Sarma on Facebook
Chief Scientific Officer
Michael Morin
  Michael Morin LinkedIn Profile  Michael Morin Twitter Account  Michael Morin News  Michael Morin on Facebook
Co-Founder
Scott Dessain
  Scott Dessain LinkedIn Profile  Scott Dessain Twitter Account  Scott Dessain News  Scott Dessain on Facebook
VP - Bus. Development
Karen Lundgren
  Karen Lundgren LinkedIn Profile  Karen Lundgren Twitter Account  Karen Lundgren News  Karen Lundgren on Facebook
VP - Engineering
Pavel Nikitin
  Pavel Nikitin LinkedIn Profile  Pavel Nikitin Twitter Account  Pavel Nikitin News  Pavel Nikitin on Facebook
VP - R & D
Lauren Pitt
  Lauren Pitt LinkedIn Profile  Lauren Pitt Twitter Account  Lauren Pitt News  Lauren Pitt on Facebook
VP - R & D
Matthew Robinson
  Matthew Robinson LinkedIn Profile  Matthew Robinson Twitter Account  Matthew Robinson News  Matthew Robinson on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/31/2017: People.ai venture capital transaction
Next: 5/31/2017: CounterTack venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary